Compound Report Overview
Compound Name:
AJMALINE
Compound Identifier:
707516
Mol Structure 2D:
707516
Molecular Weight:
326
Formula:
C20 H26 N2 O2
Development Status:
Launched outside US, not listed by FDA
SMILES:
CCC1C(O)N2C3CC45C(O)C3C1CC2C5N(C)c6ccccc64
Compound Activites
| Compound | Assay | Assay Name | View |
|---|---|---|---|
| AJMALINE | 116 | Dopamine D3 | View |
| AJMALINE | 620 | Calcium Channel Type L, Benzothiazepine | View |
| AJMALINE | 214 | Sigma2 | View |
| AJMALINE | 628 | Melanocortin MC5 | View |
| AJMALINE | 80 | Adrenergic alpha1A | View |
| AJMALINE | 82 | Adrenergic alpha1D | View |
| AJMALINE | 643 | CYP450-2D6 Inhibition | View |
| AJMALINE | 114 | Dopamine D2L | View |
| AJMALINE | 81 | Adrenergic alpha1B | View |
| AJMALINE | 86 | Adrenergic alpha2C | View |
| AJMALINE | 84 | Adrenergic alpha2A | View |
| AJMALINE | 216 | Sodium Channel, Site 2 | View |